It also dampens local inflammation and supports tendon, ligament, and muscle repair
Any references to obesity, glucose regulation, adiposity, liver function, or related biological outcomes are for research context only and must not be interpreted as medical, therapeutic, or clinical claims
While Phase II trials in heart failure and primary mitochondrial myopathy did not meet primary efficacy endpoints, the TAZPOWER trial in Barth syndrome demonstrated significant improvements in muscle strength and sixminute walk distance, leading to FDA accelerated approval in 2025 [3] [10]
This is how we ensure our results are precise and natural-appearing
DSIP research shows it can modulate GH secretory patterns by synchronizing endogenous pulsatility rather than causing non-physiological elevations